These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6157318)

  • 1. Pulmonary vascular actions of the antihistamine oxatomide during hypoxia.
    Tucker A
    Agents Actions; 1980 Jun; 10(3):207-12. PubMed ID: 6157318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of histamine antagonists to prevent hypoxic pulmonary vasoconstriction in dogs.
    Tucker A; Weir EK; Reeves JT; Grover RF
    J Appl Physiol; 1976 Apr; 40(4):496-500. PubMed ID: 6418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydralazine does not inhibit canine hypoxic pulmonary vasoconstriction.
    Bishop MJ; Kennard S; Artman LD; Cheney FW
    Am Rev Respir Dis; 1983 Dec; 128(6):998-1001. PubMed ID: 6650991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxatomide: inhibition and stimulation of histamine release from human lung and leucocytes in vitro.
    Church MK; Gradidge CF
    Agents Actions; 1980 Apr; 10(1 Pt 2):4-7. PubMed ID: 6155772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of histamine in the genesis of hypoxic pulmonary vasoconstriction: study with disodium cromoglycate].
    Rengo F; Trimarco B; Ricciardelli B; Volpe M; Violini R; Morrone G; Condorelli M
    Boll Soc Ital Cardiol; 1978; 23(9):1505-14. PubMed ID: 95434
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices].
    Ohmori K; Ishii H; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):441-9. PubMed ID: 6186585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H1- and H2-receptors in pulmonary and systemic vasculature of the dog.
    Tucker A; Weir EK; Reeves JT; Grover RF
    Am J Physiol; 1975 Oct; 229(4):1008-13. PubMed ID: 242221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M; Ishii Y; Kitamura S; Ohno S
    Respiration; 1998; 65(1):63-70. PubMed ID: 9523370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental changes in vascular responses to histamine in normoxic and hypoxic lamb lungs.
    Gordon JB; Clément de Cléty S; Chu K
    J Appl Physiol (1985); 1991 Jan; 70(1):323-30. PubMed ID: 2010388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of minoxidil and nifedipine on hypoxic pulmonary vasoconstriction in dogs.
    Bishop MJ; Cheney FW
    J Cardiovasc Pharmacol; 1983; 5(2):184-9. PubMed ID: 6188887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site of hypoxic pulmonary vasoconstriction in pulsatile perfused canine lung lobes.
    Hasebe N; Onodera S; Yamashita H; Kawamura Y; Haneda T; Tobise K
    Jpn Circ J; 1992 Aug; 56(8):837-46. PubMed ID: 1527896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of thromboxane A2 by low-dose almitrine in the hypoxic dog.
    Chuma R; Tanaka O; Hoshino Y; Obara H; Iwai S
    Eur Respir J; 1988 Aug; 1(8):706-10. PubMed ID: 3234519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of allergen-mediated histamine release from human cells by ketotifen and oxatomide. Comparison with other H1 antihistamines.
    Radermecker M
    Respiration; 1981; 41(1):45-55. PubMed ID: 6166035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contrasting influence of two lipoxygenase inhibitors on hypoxic pulmonary vasoconstriction in anesthetized pigs.
    McCormack DG; Paterson NA
    Am Rev Respir Dis; 1989 Jan; 139(1):100-5. PubMed ID: 2463778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide partially reverses hypoxic pulmonary vasoconstriction in the dog.
    Romand JA; Pinsky MR; Firestone L; Zar HA; Lancaster JR
    J Appl Physiol (1985); 1994 Mar; 76(3):1350-5. PubMed ID: 8005882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hypoxic pulmonary vasoconstriction by carbon monoxide in dogs.
    Vassalli F; Pierre S; Julien V; Bouckaert Y; Brimioulle S; Naeije R
    Crit Care Med; 2001 Feb; 29(2):359-66. PubMed ID: 11246317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute ingestion of ethanol on hemodynamics and hypoxic pulmonary vasoconstriction in dogs--role of leukotrienes.
    Lu CY; Wang DX; Yu SB
    J Tongji Med Univ; 1992; 12(4):253-6. PubMed ID: 1289577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators].
    Ohmori K; Ishii H; Nito M; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):399-409. PubMed ID: 6138301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of isoflurane on hypoxic pulmonary vasoconstriction in dogs.
    Domino KB; Borowec L; Alexander CM; Williams JJ; Chen L; Marshall C; Marshall BE
    Anesthesiology; 1986 Apr; 64(4):423-9. PubMed ID: 3963450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation.
    Höhne C; Drzimalla M; Krebs MO; Boemke W; Kaczmarczyk G
    J Physiol Pharmacol; 2003 Dec; 54(4):497-510. PubMed ID: 14726606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.